Understanding cell dynamics in animal models have implications for therapeutic strategies elaborated against leukemia in human. Quantification of the cell turnover in closely related primate systems is particularly important for rare and aggressive forms of human cancers, such as adult T-cell leukemia. For this purpose, we have measured the death and proliferation rates of the CD4 þ T lymphocyte population in squirrel monkeys (Saimiri sciureus) infected by human T-lymphotropic virus type 1 (HTLV-1). The kinetics of in vivo bromodeoxyuridine labeling revealed no modulation of the cell turnover in HTLV-1-infected monkeys with normal CD4 cell counts. In contrast, a substantial decrease in the proliferation rate of the CD4 þ T population was observed in lymphocytic monkeys (e.g. characterized by excessive proportions of CD4 þ T lymphocytes and by the presence of abnormal flower-like cells). Unexpectedly, onset of HTLV-associated leukemia thus occurs in the absence of increased CD4 þ T-cell proliferation. This dynamics significantly differs from the generalized activation of the T-cell turnover induced by other primate lymphotropic viruses like HIV and SIV.
Introduction
About 15 to 25 million people are infected worldwide by human T-lymphotropic virus type I (HTLV-1), mostly concentrated in endemic regions of Central and South America, equatorial Africa and Asia (Yoshida, 2001 ). In the vast majority of infected individuals, the virus persists indefinitely throughout life without inducing any major clinical sign. Only in about 3-5% of HTLV-1 carriers, viral infection causes either a chronic progressive neuromyelopathy (tropical spastic paraparesis/ HTLV-associated myelopathy (TSP/HAM)) (Gessain et al., 1985; Osame et al., 1986) or a malignant CD4 þ T-cell leukemia referred to as adult T-cell leukemia/ lymphoma (ATLL) (Poiesz et al., 1980; Yoshida et al., 1982) . Although the proviral loads can be particularly high in TSP patients (accounting for up to 20% of peripheral blood mononuclear cells), the relative as well as absolute CD4 levels remain in the normal range. Unaltered CD4 þ T lymphocyte counts also characterize the smoldering and lymphoma types of ATLL. In contrast, absolute CD4 lymphocytosis increases and persists during chronic ATLL, reaching levels higher than 3 Â 10 6 T lymphocytes/ml of blood (Shimoyama, 1991) . Finally, the acute phase of ATLL results from a clonal expansion of abnormal CD4 þ leukemic cells with multilobulated nuclei (flower-like or clover leaf cells) (Yamaguchi et al., 1988) . In the absence of efficient chemotherapy, the acute and lymphoma forms of ATLL have a very poor prognosis with a median survival time of 6-10 months. In contrast, smoldering and chronic ATL have a more protracted natural course, which may be restricted by aggressive chemotherapy. Besides induction of ATLL and TSP, HTLV-1 infection may indirectly cause many other diseases, possibly via the induction of immunodeficiency, such as nonspecific dermatomycosis, uveitis, strongyloidiasis, chronic lung diseases, or renal failure and monoclonal gammopathy (Pagliuca et al., 1988; Mochizuki et al., 1992; Yamaguchi, 1992) .
Animal models have been developed to better understand the biology of viral infection, describe the associated pathologies, design therapeutic strategies and evaluate the efficiency of vaccine combinations (Ishiguro et al., 1992; Lairmore et al., 1992; Bomford et al., 1996; De The and Kazanji, 1996; Kazanji et al., 2001) . For instance, mouse transgenic systems have been useful to demonstrate the presence, within the viral genome, of oncogenic determinants such as Tax (Benvenisty et al., 1992; Grossman et al., 1995; Portis et al., 2001) . Unfortunately, these systems have two limitations: either they only partially reflect the pathologies occurring in humans or they do not include an essential parameter, which is viral replication. Besides transgenics, attempts to directly infect mice with HTLV-1 resulted in inefficient viral expression and spread (Fang et al., 1998) . The defect, which is probably situated at the level of Rex and protease activities, could be overcome by replacement of the env gene with the corresponding envelope sequence of an ecotropic Moloney murine leukemia virus (Delebecque et al., 2002) . Transgenics and direct HTLV infection in rats yielded various pathologies (thymoma, chronic destructive arthritis) and made it possible to evaluate the immune response (cytotoxic activity, involvement of major histocompatibility complex class I downregulation), to assess therapeutic strategies (vaccination, adoptive transfer) and to test the routes of infection (Kazanji et al., 1997a; Ohashi et al., 2000 Ohashi et al., , 2002 Hanabuchi et al., 2001; Nakamaru et al., 2001; Kikuchi et al., 2002; Sugaya et al., 2002; Hasegawa et al., 2003) . A major contribution of another species, the rabbit, was the identification of viral genetic determinants required for HTLV-1 infectivity and pathogenesis (Leno et al., 1995; Collins et al., 1998; Simpson et al., 1998; Bartoe et al., 2000) .
None of the models, however, completely replicates the natural pathogenesis, including viral infection, host cell specificity and clinical outcome. Besides alternative strategies based on comparative pathogenesis (i.e. Simian T-lymphotropic virus in monkeys and bovine leukemia virus in cattle) (Akari et al., 1998; Willems et al., 2000) and considering the difficulties associated with direct experimentation in human, our tenet is that non-human primates might be the closest animal models for studying HTLV-associated pathogenesis (Yamanouchi et al., 1985; Ichimaru et al., 1991; Ibuki et al., 1997; Kazanji, 2000) . In this context, the new-world squirrel monkey, Saimiri sciureus, combines two major advantages of being free of the related STLV-1 and of developing a persistent infection, possibly followed by lymphocytosis upon experimental inoculation with HTLV-1 (Kazanji et al., 1997b) . The adequacy of the model is further supported by the target cell specificity, the CD4 þ T-helper lymphocyte, and by a common replication strategy dominated by clonal expansion (Mortreux et al., 2001a) . As in the humans, indeed, HTLV infection of the squirrel monkey possibly leads, after extended clinical latency, to the continuous expansion of a restricted number of abundant cellular clones. This mode of infected lymphocyte expansion results from an imbalance between the net input of cells and/or their disappearance by apoptosis. In this context, we aimed to measure the relative rates of proliferation and death in S. sciureus experimentally infected by HTLV-1.
Results

CD4 lymphocytosis in HTLV-1-infected squirrel monkeys
Homeostatic regulation of the cell numbers in the peripheral blood results from an equilibrium between proliferation and cell death. To investigate the influence of HTLV-1 infection on lymphocyte homeostasis, we aimed to quantify the cell turnover in HTLV-1-infected squirrel monkeys. For this purpose, the proliferation and death rates were determined in two animals persistently infected with HTLV-1 (no. 1540 and 1715), as well as in seronegative controls (no. 94027 and 92048). With similar CD4 þ T-cell counts, the hematological parameters of these four monkeys were in the normal range (between 0.53 and 0.67 million CD4-positive T lymphocytes/ml, Table 1A ). The evaluation of the proviral loads by real-time PCR indicated that animals no. 1540 and 1715 had, respectively, 2.23 and 4.32% infected lymphocytes in the PBMC population (Table 1B) .
To further characterize HTLV-1 infection in these two animals, proviral integration sites were amplified by inverse PCR (IPCR), allowing specific detection of + T cells (% of CD4 + T cells). The numbers of lymphocytes per milliliter were counted using a Pentra 60 apparatus (ABX Diagnostics). Absolute numbers of CD4 + T lymphocytes were calculated by multiplying the numbers of lymphocytes Â 10 6 /ml with the percentages of CD4 + T cells. (B) Quantification of HTLV-1 proviral load in monkeys no. 1540, 1715, 1491 and 94119. Real-time PCR quantification was performed using the LightCycler system and Taqman probes for HTLV-1 tax and albumin amplification. Standard curves for albumin and HTLV-1 tax genes were generated using DNA extracted from control PBMCs and a HTLV-1 cell line (TARL-2), respectively. Each sample was analysed in triplicate, using 150 ng of DNA for tax and 10 ng for albumin in each reaction (number of viral copies/150 ng of DNA). From the estimation that 10 ng of highmolecular-weight DNA (equivalent to roughly 1500 PBMCs) would contain 3000 copies (two copies per PBMCs) of the albumin gene, percentages of infected cells were measured in monkeys (% of infected cells) and absolute numbers of infected cells were calculated Cell dynamics in HTLV-1 infected monkeys C Debacq et al cellular flanking sequences as well as semiquantitative estimation of their relative frequencies. As a positive control, IPCR of the human lymphocytic C91PL cell line yielded numerous fragments indicating the integration of many HTLV-1 proviral copies, as expected ( Figure 1a) . The numbers and frequencies of the amplified fragments were limited in monkeys no. 1540 and 1715 with two and three dominant integration sites, respectively. The quadruplicate repetition of one of these sites (fragment between 201 and 220 base pairs in sample 1715) is indicative of its relative abundance (more than one in 150 PBMCs). These IPCR assays thus confirm the proviral quantification data, as assessed by real-time polymerase chain reaction, and indicate that these infected monkeys had clones of infected T cells which had undergone considerable expansion. In the absence of typical flower-like leukemic cells, the infection levels and the integration patterns of monkeys 1540 and 1715 are thus reminiscent of an asymptomatic or preclinical phase of disease in humans (e.g. below 1% of infected cells in asymptomatic patients versus more than 7-10% during TSP associated with normal CD4 counts).
ATL in human is a rare neoplastic transformation of CD4 þ T lymphocytes occurring in a minority of HTLV-1-infected people (3-5%) after extended latency periods (several decades) (Yoshida, 2001 ). Chronic ATL is characterized by the expansion of CD4 þ leukemic clones and by the presence of abnormal flower-like cells. Interestingly, the pathology affecting two HTLV-1-infected squirrel monkeys (no 1491 and 94119) fitted well to these hematological criteria: these animals had high proportions of CD4 þ T cells (63.54 and 54.26%, respectively), concomitantly with an increase in the total CD4 population (6.96 and 1.61 millions/ml, respectively) (Table 1A) .
In monkey 1491, 3.5% of lymphocytes were infected (Table 1B) . Furthermore, IPCR revealed the presence of several proviral integration sites, among which two were repeated four times ( Figure 1b) . One of these clones (shorter than 134 base pairs) persisted after twofold dilution of the genomic DNA, followed by IPCR (three Figure 1 Identification of the HTLV integration sites into the cellular genome. DNA (500 ng) from monkeys no. 1540, 1715 (panel a) and 1491 (panels b and c) was amplified by IPCR analyses in order to identify the 3 0 HTLV-1 integration sites. Each sample was analysed in quadruplicate and run-off products were resolved on a denaturing gel. DNA extracted from C91PL and Jurkat cells was used as positive and negative controls, respectively. A fragment called 'TG' is generated by amplification of a CA dinucleotide present at the end of the viral LTR juxtaposed to a TG in the cellular genome. This IPCR fragment thus corresponds to the minimal integration site. MW are the molecular weight markers (positions are indicated in nucleotides). To identify the major integration site, the DNA of monkey 1491 was diluted two (Dil. 2 Â ) and four times (Dil. 4 Â ) with DNA from Jurkat T-cell line prior to IPCR (panel c).
LMPCR was performed with 94119 DNA (panel d)
Cell dynamics in HTLV-1 infected monkeys C Debacq et al amplifications out of four; two out of four after an additional dilution as observed on an overexposed blot, data not shown), indicating its predominance in the lymphocyte population of animal 1491 ( Figure 1c ). In contrast, additional dilution of DNA isolated from asymptomatic HTLV-infected monkey 1715 did not generate any IPCR signal (data not shown).
Despite the presence of excessive proportions of CD4 þ T lymphocytes, the proviral loads in monkey 94119 were low (0.1% of infected cells, Table 1B ). Ligation-mediated PCR (LMPCR), a technique which is more sensitive than IPCR, permitted the identification of six integration sites (Figure 1d ).
Besides the characterization of the integration sites, the phenotype of peripheral blood cells was directly examined under the light microscope. Interestingly, blood smears revealed that two monkeys (1491 and 94119) harbored abnormal clover leaf lymphocytes (Figure 2 ), as typically observed in human patients affected by ATL. These cell types were not encountered in other HTLV-infected asymptomatic or control monkeys.
Together, these data indicate that two monkeys (1491 and 94119) had features of chronic ATL, that is, (i) an increase in the circulating CD4 þ T lymphocyte count, (ii) the expansion of a limited number of clones (no10) and (iii) the presence within the peripheral blood of abnormal flower-like cells.
The CD4 cell turnover is not modified in asymptomatic HTLV-1-infected monkeys
To quantify the proliferation and death rates in these monkeys, a single injection of bromodeoxyuridine (BrdU) was administered to the four animals (no. 1540, 1715, 92048 and 94027) and blood was collected at regular time intervals. CD4 þ T lymphocytes were purified by Ficoll gradient centrifugation, followed by magnetic microbead cell sorting, and BrdU incorporation within the CD4 population was then quantified by flow cytometry. As expected from this pulse-chase experiment, the BrdU incorporation levels rose from undetectable background levels to about 2-3% 3 days post-injection (Figure 3) . Then, the proportion of labeled CD4 þ T cells gradually decreased, reflecting the lack of further BrdU incorporation.
Interpretation of this experiment requires mathematical modeling in order to define the kinetic parameters (e.g. p for proliferation and d for death) sustaining the CD4 population dynamics (see Materials and methods). The model was fitted to the BrdU incorporation data (theoretical fit, Figure 3) , resulting in an estimate of p and d for each animal as given in Figure 4a . The proliferation rate is an estimate of the proportion of CD4 þ T cells that divide in a day (e.g. in monkey 94027, if p ¼ 0.031 day À1 , then approximately 3.1% of all CD4 þ T lymphocytes proliferate in a day). Similarly, the death rate 0.085 day À1 is the proportion of labeled CD4 þ T cells that die in that animal in a day. Based on the measured incorporation levels, the proliferation and death rates were calculated for all four monkeys ( Figure 4a ). Mean values of these parameters were not significantly different between the two categories of animals (i.e. uninfected versus HTLV-1 infected). We conclude that the turnover of the CD4 þ T-cell population was not modified in virus-infected monkeys no. 1540 and 1715 compared to the normal controls.
Reduced CD4 cell turnover in lymphocytic HTLV-1-infected monkeys
Characterized by an excess of CD4 þ T lymphocytes and by the presence of abnormal flower-like cells, monkeys 1491 and 94119 provided a unique opportunity to study cell dynamics in a model system that has certain features in common with chronic ATL in human. For this purpose, a pulse-chase BrdU experiment was performed as described before, and the BrdU incorporation levels within the CD4 population were determined at regular time intervals (Figure 3 ). Fitting these data to the mathematical model generated estimates of the rates of proliferation and death (p ¼ 0.017 and 0.013 and d ¼ 0.107 and 0.070, respectively for animals no. 1491 and 94119; Figure 4a ). Compared with the nonlymphocytic HTLV-1-infected monkeys (no. 1540 and 1715) and to the controls (no. 94027 and 92048), the death rates of the 1491 and 94119 CD4 þ T-cell populations were not significantly different (0.087 and 0.089, respectively; Figure 4a and illustrated in Figure 4c ). In contrast, the CD4 þ T-cell proliferation rate measured in lymphocytic monkeys was drastically reduced (0.015 versus 0.033 in controls and low CD4 monkeys; Figure 4a ), the difference being statistically significant (Po0.05, two-tailed unpaired Students t-test) (Figure 4b) . In other words, in lymphocytic monkeys 1491 and 94119, cell death is unaffected but proliferation is reduced. Surprisingly, accumulation of CD4 T cells in these monkeys is thus not associated with increased CD4 proliferation.
Discussion
Characterized by different clinical manifestations (e.g. acute, smoldering, chronic and lymphoma), ATL is a Cell dynamics in HTLV-1 infected monkeys C Debacq et al rare disease that affects a minority of HTLV-1-infected people (3-5%) after extended latency periods (10-70 years) (Yoshida, 2001) . In this context, an animal model may make it possible to get insights into the dynamic parameters leading to the onset of leukemia. In this report, we have quantified the cell turnover in a primate system, that is, S. sciureus infected by HTLV-1. In particular, monkeys no. 1491 and 94119 provided a rare opportunity to determine the proliferation and death rates at a pathological stage resembling chronic ATL: increase in the relative and absolute proportions of CD4 þ T lymphocytes and presence of flower cells in the peripheral blood. We have demonstrated that, unexpectedly, the proliferation rates of the CD4 þ populations in animals no. 1491 and 94119 were lower than those in the asymptomatic and uninfected controls.
Our data thus fit into a model postulating that proliferation is reduced in lymphocytic HTLV-1-infected monkeys. Since the numbers of cells remained relatively constant during the experiment, the lack of a Figure 3 Cell dynamics in HTLV-1-infected monkeys. Four HTLV-1-infected monkeys (low CD4: no. 1540 and 1715; high CD4: no. 1491 and 94119) and two controls (no. 94027 and 92048) were injected intravenously with 10 mg of BrdU. Blood samples from monkeys were collected at different days after a single pulse of BrdU injection. PBMCs were isolated and CD4 þ T cells were purified by magnetic microbeads coupled with anti-human CD4 monoclonal antibody. Then, the cells were stained with anti-BrdU FITC antibody in the presence of DNase and analysed by flow cytometry. The percentages of BrdU-positive cells within the CD4 þ T-cell population were determined and the data corresponding to the measured incorporation rates were analysed with a mathematical model, yielding theoretical fit curves Cell dynamics in HTLV-1 infected monkeys C Debacq et al corresponding decrease in death rates generates an apparent discrepancy. However, the parameter p corresponds to the proliferation rate of all CD4 þ T cells, whereas d measures the death of the BrdU-labeled population alone (see the model in Figure 5 ). For this reason, it is possible for p to decrease and d to remain constant, while cell numbers are unaffected or even rise. This happens if there is a decrease in death rate of cells that remain quiescent or divide infrequently. Under these conditions, the average death rate of the whole population is reduced. However, this reduction may not be evident in the BrdU labeling, because BrdU is incorporated only into cells that proliferate during the brief period of availability of the label, so that rapidly proliferating cells are preferentially labeled. To summarize: it appears that the decreased death rate of slowly proliferating cells outweighs the decreased average proliferation rate of the whole population, and, as a Figure 5 Model summarizing the dynamic parameters. During the experiment, the numbers of cells remained relatively constant in the controls as well as in the infected monkeys. The proliferation rate p, which corresponds to the proliferation rate of all cells, is reduced in lymphocytic HTLV-1-infected monkeys generating a smaller population of BrdU-labeled cells. The death rate d remains constant in both categories of monkeys. If cell numbers are unaffected, the model postulates that the death rate of cells that divide infrequently and that do not become labeled by BrdU decreases. Under these conditions, the average death rate of the whole population is reduced; yet the total cell numbers remain constant Figure 4 Proliferation and death rates in HTLV-1-infected monkeys. (a) Minimal proliferation and death rates (7standard deviations (s.d.)) were estimated from fitting a theoretical model to the BrdU incorporation data presented in Figure 3 . The standard deviations on the individual parameters are the reflection of the confidence level in the estimated parameters. Mean values were calculated for monkeys with high CD4 counts (1491 and 94119) and a group composed by the other animals (uninfected and HTLV-1-positive low CD4 monkeys; noninfected (NI) þ low CD4). The standard deviations of the mean values reflect the variability within each group. Panels b and c are graphic representations of the minimal proliferation and death rates, respectively. Mean values of two NI controls, two HTLV-1-positive animals with low levels of CD4 þ T cells, and two lymphocytic monkeys (e.g. with high CD4 counts) are represented. * means that the difference between the proliferation rate of the high CD4 monkeys no. 1491 and 94119 compared with those of the NI þ low CD4 animals is statistically significant (Po0.05 according to the two-tailed unpaired Student's t-test). NS means nonstatistically significant Cell dynamics in HTLV-1 infected monkeys C Debacq et al consequence, the circulating cell number progressively rises.
A point that merits discussion is the amount of BrdU used. It remained indeed possible that limiting doses of BrdU were insufficient to label all proliferating cells in the lymphocytic monkeys (i.e. those having more CD4 þ T lymphocytes). In this context, it should be mentioned that S. sciureus can transiently develop high lymphocyte counts under particularly high-stress conditions consecutive to their capture from the wild (F Merien, personal observations). We determined the dynamic parameters in one of these uninfected lymphocytic monkeys (no. 94041) and estimated the proliferation and death rates at p ¼ 0.072 and d ¼ 0.135, respectively (data not shown). Since this p value exceeds by far those measured both in HTLV-1-infected animals and in other normal controls, it appears that transient stress-induced lymphocytosis is associated with increased proliferation. This process, which is thus significantly different from the dynamics observed in HTLV-1-infected monkeys, also demonstrates that the BrdU doses were not a limiting step in our experiments.
In lymphocytic HTLV-1-infected monkeys no. 1491 and 94119, the decreased proliferation rate of the CD4 þ T cells may be dictated by differences in the kinetics of defined subpopulations. As explained above, it is possible that the high CD4 þ T-cell count was due to an enrichment in a infrequently proliferating subpopulation of CD4
þ T lymphocytes such as naı¨ve (CD45-RA) or memory (CD45-RO) cells. Thymic production of CD45-RA naı¨ve cells has been shown to be impaired in HTLV-1-infected human patients based on quantification of T-cell receptor rearrangement excision circles (Yasunaga et al., 2001) . In the human, HTLV-1 also infects CD8 cytotoxic T cells but preferentially propagates in CD4 þ CD45-RO þ memory lymphocytes. Moreover, ATL is characterized by the clonal expansion of CD4 þ T cells expressing the CD45-RO marker, further illustrating the involvement of specific T lymphocyte subpopulations in the human pathology. In the absence of anti-human CD45-RA and CD45-RO antibodies which crossreact with the monkey counterparts, the dynamics of these subpopulations in HTLV-1-infected S. sciureus could not be addressed.
Although we did not investigate the metabolic pathways involved in cell dynamics, it is likely that the HTLV-1 regulatory proteins are key modulators of this process. In this context, p13-expressing Jurkat T cells exhibit reduced proliferation, suggesting a negative regulator role of p13 on the cell growth (Silic-Benussi et al., 2004) . Alternatively, the Tax transactivator protein harbors a wide variety of different functions including activation as well as repression of cellular gene transcription, promotion of the cell cycle, interference with apoptosis (both negatively and positively), and facilitation of chromosomal aberrations (Yoshida, 2001; Jeang et al., 2004) . However, it is difficult to prove a link between these pleiotropic in vitro activities of Tax and the parameters of lymphocyte dynamics in vivo. If the death rates reflect an apoptotic process that can be experimentally measured in vitro, it is difficult to reconcile the cell cycle promotion function of Tax with reduced proliferation observed in vivo. Importantly, Tax expression is undetectable in freshly isolated leukemic lymphocytes from ATL patients in the absence of in vitro cell culture. Chronic Tax expression is not thus required to maintain leukemic cell persistence in vivo. If this is transposable to monkeys no. 1491 and 94119, flower cell growth would also be independent of the Tax transactivator. Therefore, we postulate that leukemic cell persistence and proliferation have been triggered by chromosomal abnormalities, as suggested by the flower cell phenotype. CD4 þ T lymphocyte dynamics have been characterized in the context of infections by other CD4-tropic primate retroviruses: Simian immunodeficiency virus (SIV) and Human immunodeficiency virus (HIV). Several-fold increased proliferation and death rates have been measured both in monkeys and humans (Mohri et al., 1998 (Mohri et al., , 2001 Rosenzweig et al., 1998; Kovacs et al., 2001; Ribeiro et al., 2002) , suggesting a global activation of the immune system caused by SIV or HIV replication. Kinetic parameters were substantially reduced after antiretroviral therapy and reached normal levels in parallel with the reduction of the proviral loads (Mohri et al., 2001 ). These observations indicate that CD4 þ T-lymphocyte depletion associated with AIDS is primarily the consequence of increased turnover. This generalized activation of the T-cell turnover induced by other CD4 tropic retroviruses like HIV and SIV thus significantly differs from the dynamics associated with HTLV-induced leukemia in monkeys described here.
To conclude, we have determined the proliferation and death rates in S. sciureus monkeys as a primate model for HTLV-1 pathogenesis in human. A substantial and statistically significant decrease in the proliferation rate of the CD4 þ T population was observed in HTLV-1-infected monkeys affected by a pathology sharing characteristics with chronic ATL in human. Although it could be hazardous to generalize the kinetic parameters defined in this report, we have demonstrated here that the turnover of the T-lymphocyte population is decreased at least in the two rare cases of lymphocytic animals. These observations supporting a use of proapoptotic rather than antiproliferative chemicals might have important consequences for elaborating therapeutic strategies against ATL in human.
Materials and methods
Experimental monkeys
Male Squirrel monkeys (S. sciureus) (no. 1491, 1540, 1715, 92048, 94027, 94041 and 94119) were bred and housed at the Primatology Center of the Institut Pasteur de la Guyane in French Guiana according to the legislation for animal experiments. Monkeys no. 1491, 1540, 1715 and 94119 were infected by HTLV-1 as reported previously (Kazanji et al., 1997b) , whereas animals no. 92048, 94027 and 94041 were used as uninfected controls. At regular intervals of time, the numbers of leucocytes and lymphocytes were counted using Cell dynamics in HTLV-1 infected monkeys C Debacq et al a Pentra 60 apparatus (ABX Diagnostics). To measure the percentage of CD4 þ T lymphocytes, 1 ml of blood from each monkey was collected, red blood cells were lysed with 1 Â FACS Lysing Solution (Becton Dickinson Immunocytometry Systems), and leucocytes were incubated in the presence of phycoerythrin-conjugated anti-human CD4 þ T cells (leu-3a; clone SK3) (Becton Dickinson Immunocytometry Systems). Finally, cells were analysed on a Becton Dickinson FACScan flow cytometer using the CELLQUEST software (Becton Dickinson Immunocytometry Systems). Flower cells in blood smears from monkeys no. 1491 and 94119 were visualized under the light microscope after fixation with methanol and staining with Ral 555 s (fast stain of May-Gru¨nwald Giemsa).
HTLV-1 proviral load quantitation
Real-time PCR quantification was performed using the LightCycler system with the LightCycler FastStart DNA Master Hybridization probes kit (Roche Applied Science) and Taqman probes for HTLV-1 and albumin amplification (as described by Mortreux et al., 2001b) . Standard curves for albumin and HTLV-1 tax genes were generated using DNA extracted from HTLV-1-negative PBMCs and a HTLV-1 monoclonal cell line (TARL-2), respectively. The primer set for the HTLV-1 tax gene was PXF 5 0 -CAAACCGTCAAGCA CAGCTT-3 0 and PXR 5 0 -TCTCCAAACACGTAGAC TGGGT-3 0 (positioned at 7163-7182 and 7385-7364, respectively, according to Genbank accession number J02029 M33896 clone AKT (Seiki et al., 1983) ). Primers for albumin were ALBF 5 0 -GCTGTCATCTCTTGTGGGCTGT-3 0 and ALBR 5 0 -ACTCATGGGAGCTGCTGGTTC-3 0 located, respectively, at 16 283-16 304 and 16 442-16 421 (nucleotide coordinates are numbered according to the albumin Genbank reference: HUMALBGC). The probes for the HTLV-1 tax and the albumin genes were PXT (5 0 -TTCCCAGGGTTTGGA CAGAGTCTTCT-3 0 positioned at 7331-7355) and ALBT (5 0 -CCTGTCATGCCCACACAAATCTCTCC-3 0 at 16 340-16 366), respectively. Tax or albumin amplifications were carried out in 20 ml of a PCR mixture containing, respectively, 1 or 2 ml of 25 mM MgCl 2 , 2.5 or 4 pmol of probe, 2 ml of 10 Â ready-to-use 'Hot Start' reaction mix for PCR and 10 pmol of each primer. The PCR protocol consisted of a 8-min denaturing step at 951C, followed by 45 cycles of 10 s at 951C, 1 min at 601C. Each sample was analysed in triplicate, using 150 ng of DNA for tax and 10 ng for albumin in each reaction. Uninfected DNA sample and water served as negative controls.
Molecular detection and semiquantitative analysis of HTLV-1 integration
Inverse polymerase chain reaction (IPCR) analysis of the HTLV-1 integration sites permits the amplification of the 3 0 extremities of the proviruses together with their flanking sequences (Mortreux et al., 2001b) . Quadruplicate IPCR analysis also provides a semiquantitative estimation of HTLV-1 integration sites: above X1000 copies (diluted in 1 mg, B150 000 cell equivalents), the frequency of detection was 4 out of 4, whereas at 500, 100 and o80 copies, amplification occurred in three, one, and zero out of four reactions, respectively. In all, 2 mg DNA was digested with 20 U NlaIII restriction endonuclease (New England Biolabs) during 3 h at 371C. The completion of the digestion was controlled by 1% agarose gel electrophoresis. DNA was extracted with phenol-chloroform (1 : 1) and precipitated with 100% ethanol. In all, 1 mg of digested DNA was circularized for 14 h at 161C with 20 U of T4 DNA ligase (New England Biolabs) in 600 ml of 1 Â T4 DNA ligase buffer and 1 mM adenosine triphosphate. DNA was extracted with phenolchloroform (1 : 1) and precipitated with 100% ethanol. Samples were analysed through quadruplicate experiments: 4 Â 500 ng of circularized DNA was amplified by 30 cycles of PCR using 200 mM of primers BIO6 5 0 -CTCCTGCTAGTTTA TTGAGCCATA-3 0 at position 8621-8598) and LTR1 (5 0 -TC GCATCTCTCCTTCACGCG-3 0 at position 8657-8675; nucleotide coordinates are numbered according to the HTLV-1 reference sequence on ATK-1). Amplifications were performed with Taq DNA polymerase (Roche Applied Bioscience). Thermal cycling parameters were: 961C for 10 min and 40 times at 961C for 60 s, 581C for 60 s, and 721C for 3 min, followed by a final elongation step of 10 min at 721C. The length polymorphism generated by PCR amplification of HTLV-1 flanking sequences was revealed by a linear PCR amplification of both the 3 0 extremity of the provirus and its flanking sequence (e.g. a runoff). In all, 2 ml of amplified product was submitted to 10 cycles of linear PCR with 2 mM of 5 0 -32 P radiolabeled primer BIO5 (5 0 -TGGCTCGGAGCCA GCGACAGCCCAT-3 0 ) (nucleotide coordinates 8995-9020), 1 U of the Stoffel fragment of the Taq DNA polymerase (Perkin-Elmer Applied Biosystems) and 200 mM of each deoxynucleoside triphosphate in a final volume of 20 ml. The thermal cycling parameters were as follows: 951C for 10 min and 10 times at 951C for 60 s, 581C for 60 s, and 721C for 3 min, followed by a final elongation step of 10 min at 721C. After boiling in deionized water, 2 ml of runoff products was analysed on a 6% sequencing gel. In order to identify the HTLV-1 major clones, samples of DNA were diluted prior to IPCR with DNA extracted from the Jurkat T-cell line.
LMPCR with 94119 DNA was performed as described elsewhere (Mortreux et al., 2001a) . Briefly, DNA was digested with NlaIII in 1 Â NlaIII buffer for 3 h at 371C, extracted with phenol-chloroform and precipitated in ethanol. Digested DNA was ligated to primer BIO1 (5 0 -TCATGATCAATGGG ACGATCACATG-3 0 ) using T4 DNA ligase. After two phenol-chloroform extractions, ligated DNA was amplified with 50 pmol of primer BIO2 (5 0 -CTGTTCTGCGCCGTTAC AGATCGA-3 0 ) in 1Â Stoffel DNA polymerase buffer, 1.5 mM MgCl 2 , 150 mM each deoxynucleoside triphosphate, and 10 U of Stoffel fragment of Taq DNA polymerase. Thermal cycling parameters were 941C for 10 min; 100 cycles at 951C for 45 s, 601C for 45 s, and 721C for 2 min; and a final elongation step of 10 min at 721C. In all, 10 ml of this linear PCR mixture was used in a classical PCR amplification using the primers BIO3 (5 0 -CCTTTCATTCACGACTGACTGC CG-3 0 ) and BIO4 (5 0 -TCATGATCAATGGGACGATCA-3 0 ). Amplification conditions were as before, with 40 pmol of each primer and 2.5 U of Taq polymerase in a final volume of 100 ml. Thermal cycling parameters were 941C for 10 min; 35 cycles at 951C for 45 s, 581C for 45 s, and 721C for 1 min, and a final elongation step of 10 min at 721C. The length polymorphism generated by PCR amplification of HTLV-1 flanking sequences was revealed by a linear PCR amplification using the 5 0 -32 P radiolabeled primer BIO5 as described above.
Analysis of 5-bromo-2 0 -deoxyuridine in vivo
Monkeys were injected intravenously with 10 mg of 5-bromo-2 0 -deoxyuridine BrdU (Sigma Aldrich) resuspended in NaCl 0.9% and blood was collected at regular intervals of time. PBMCs were isolated by Ficoll gradient centrifugation and resuspended in PBS supplemented with 2 mM EDTA and 0.5% BSA. CD4 þ T lymphocytes were purified by magnetic microbeads coupled with anti-human CD4 chain monoclonal antibody Leu-3a, clone M-T321 (miniMACS system, Miltenyi
Cell dynamics in HTLV-1 infected monkeys C Debacq et al Biotech). This initial cell purification step was mandatory because of the incompatibility of the CD4 and BrdU stainings. CD4 þ T lymphocytes were next washed twice in PBS containing 0.5% BSA, treated with 1 Â FACS permeabilizing solution (Becton Dickinson Immunocytometry Systems), and incubated for 10 min at room temperature. Finally, CD4
þ T lymphocytes were stained with anti-BrdU FITC antibody in the presence of DNase (Becton Dickinson Immunocytometry Systems) and analysed by flow cytometry.
Mathematical modeling
The proliferation rate (p) and the death rate (d) of CD4 þ T cells was estimated by fitting the dl=dt ¼ 2spð1 À lÞ þ ðp À dÞl ðÃÞ mathematical model to the BrdU labeling data from each animal. Here l denotes the proportion of CD4 þ T cells that are labeled, p corresponds to the average proliferation rate of CD4 þ T cells, d denotes the average death rate of labeled CD4 þ T cells and s is the probability that a proliferating CD4 þ T cell becomes labeled. The probability that a proliferating CD4
þ T cell becomes labeled is assumed to be an exponentially decreasing function of time, s ¼ e
Àat
, reflecting the loss of unincorporated BrdU from the cytoplasm of CD4 þ T cells (i.e. as the time since the BrdU injection increases, the probability of a dividing cell being labeled decreases dramatically because unincorporated BrdU is rapidly cleared). The rate of loss of BrdU was assumed to be the same in all animals as there is no physiological reason for it to vary and using the same rate improves comparability between the animals. This model is then fitted to the data using nonlinear least-squares regression, resulting in estimates of p and d for each animal. The proliferation (or death) rate is an estimate of the proportion of CD4 þ T cells that proliferate (or die) in a day. The standard error of the parameter estimates was calculated using the asymptotic covariance matrix method. Numerical simulations suggest that, for this model (*) and data sets similar to ours, the asymptotic covariance matrix method is preferable to the bootstrap method. The model used here (*) was previously used to analyse similar data in BLV-infected sheep and cattle (Debacq et al., 2003) . When first formulating this model, a number of plausible models were also developed and fit to the data in order to check that our parameter estimates were robust to changes in the model. In every case, these plausible models either failed to fitted the data (in which case they were discarded as unrealistic) or gave parameter estimates very similar to those obtained previously by fitting model (*). This indicated that our parameter estimates were robust to the above model changes. Additional details concerning the mathematical model were discussed in a previous paper .
